Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, CanadaIlan S Schwartz, Daniel Z P Friedman, Lori Zapernick, et al.The American Journal of Tropical Medicine and Hygiene|November 7, 2007
Cluster of cases of hantavirus pulmonary syndrome in Alberta, CanadaDuncan Webster, Bonita Lee, Ari Joffe, et al.Journal of Autoimmunity|May 26, 2024
Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndromeSuguru Saito, Shima Shahbaz, Mohammed Osman, et al.Mbio|May 5, 2021
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 InfectionNajmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, et al.Hypertension (Dallas, Tex. : 1979)|November 30, 2021
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ InjuriesKaiming Wang, Mahmoud Gheblawi, Anish Nikhanj, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 3, 2023
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipientsVardhil Ghandi, David Li, Justin Weinkauf, et al.Trials|March 5, 2022
LIBERATE: a study protocol for midodrine for the early liberation from vasopressor support in the intensive care unit (LIBERATE): protocol for a randomized controlled trialDawn Opgenorth, Nadia Baig, Kirsten Fiest, et al.Blood Advances|October 19, 2020
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19Mohammed Osman, Rehan M Faridi, Wendy Sligl, et al.Journal of Intensive Care Medicine|December 13, 2021
Needs Assessment Survey Identifying Research Processes Which may be Improved by Automation or Artificial Intelligence: ICU Community Modeling and Artificial Intelligence to Improve Efficiency (ICU-Comma)Vincent I Lau, Alexandra Binnie, John Basmaji, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2026
Duration of therapy for Pseudomonas aeruginosa bacteremia - a post hoc subgroup analysis from the BALANCE randomized controlled trialDafna Yahav, Ruxandra Pinto, Deborah Cook, et al.Pageof 5